Related Experiment Video
Updated: Jun 26, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
AI-based pipeline for early screening of lung cancer: integrating radiology, clinical, and genomics data
Ullas Batra1, Shrinidhi Nathany1, Swarsat Kaushik Nath2
1Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
An AI system can predict Epidermal Growth Factor Receptor (EGFR) mutations in lung cancer using CT scans. This offers a cost-effective, non-invasive method for patients, especially in resource-limited settings.
Area of Science:
- Oncology
- Radiology
- Artificial Intelligence
Background:
- Lung carcinoma prognosis improved with targeted therapies for molecular targets like Epidermal Growth Factor Receptor (EGFR) mutations.
- Next-generation sequencing for EGFR mutation detection is not widely accessible in resource-limited countries like India.
- Intratumoral heterogeneity and tissue adequacy challenges necessitate AI-driven solutions for lung nodule analysis and EGFR mutation prediction.
Purpose of the Study:
- To develop and evaluate an AI-based pipeline for automatic lung nodule detection and characterization from CT images.
- To predict the probability of EGFR mutations in lung carcinoma patients using AI models.
- To provide a cost-effective and non-invasive method for EGFR mutation status determination in resource-limited settings.
Main Methods:
- Utilized CT imaging and EGFR gene sequencing data from 2277 lung carcinoma patients across multiple cohorts.
- Trained an AI system (AIPS-Nodule or AIPS-N) for automatic lung nodule detection and feature prediction.
- Developed an AIPS-Mutation (AIPS-M) model combining AIPS-N results with clinical factors to predict EGFR genotype, evaluated using Area Under the Curve (AUC).
Main Results:
- AIPS-N demonstrated effective lung nodule detection with an average AP50 of 70.19% and predicted five lung nodule properties.
- The AIPS-M models (machine learning and deep learning) achieved AUCs ranging from 0.587 to 0.910 in predicting EGFR genotype.
- The AI system successfully identified patients with EGFR mutations.
Conclusions:
- CT imaging combined with an automated AI lung nodule analysis system can predict EGFR genotype.
- This AI-driven approach offers a cost-effective and non-invasive method for identifying EGFR mutations in lung cancer patients.
- The system aids oncologists and patients in resource-limited settings to achieve optimal care and therapy selection.
More Related Videos
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017